Intech Investment Management LLC Sells 78,037 Shares of Humana Inc. (NYSE:HUM)

Intech Investment Management LLC decreased its stake in Humana Inc. (NYSE:HUM - Free Report) by 68.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 36,172 shares of the insurance provider's stock after selling 78,037 shares during the period. Intech Investment Management LLC's holdings in Humana were worth $9,177,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in HUM. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the fourth quarter worth $27,000. Centricity Wealth Management LLC bought a new position in Humana during the fourth quarter valued at about $30,000. LFA Lugano Financial Advisors SA boosted its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana in the 4th quarter worth approximately $33,000. Finally, Atwood & Palmer Inc. boosted its holdings in shares of Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have commented on the stock. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley cut their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. StockNews.com cut shares of Humana from a "buy" rating to a "hold" rating in a research note on Tuesday, March 18th. Finally, Truist Financial boosted their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $285.68.

Remove Ads

Insider Activity at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.37% of the stock is owned by corporate insiders.

Humana Trading Down 0.2 %

NYSE:HUM traded down $0.50 during trading hours on Friday, reaching $266.33. The company's stock had a trading volume of 1,963,596 shares, compared to its average volume of 1,716,116. The firm has a market capitalization of $32.14 billion, a price-to-earnings ratio of 26.77, a PEG ratio of 2.05 and a beta of 0.57. The firm has a 50-day simple moving average of $271.33 and a 200-day simple moving average of $276.92. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.